ZENTALIS PHARMACEUTICALS INC (ZNTL) Stock Earnings Estimates
NASDAQ:ZNTL • US98943L1070
2.42 USD
-0.1 (-3.97%)
At close: Feb 20, 2026
2.2855 USD
-0.13 (-5.56%)
After Hours: 2/20/2026, 8:11:40 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 67.425M | -100.00% | 12.539M | 51.506M 310.77% | 165.39M 221.11% | 275.6M 66.64% | 436.34M 58.32% | 589.65M 35.14% | 708.51M 20.16% | ||||
| EBITDA YoY % growth | -225.86M -9.01% | -247.552M -9.60% | -186.169M 24.80% | -146.544M 21.28% | -165.644M -13.03% | -143.711M 13.24% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -227.29M -9.41% | -248.941M -9.53% | -187.458M 24.70% | -153.458M 18.14% | -157.151M -2.41% | -158.894M -1.11% | -156.023M 1.81% | -77.347M 50.43% | -7.862M 89.84% | 97.865M 1,344.80% | 180.54M 84.48% | 245.88M 36.19% | |
| Operating Margin | N/A | N/A | -278.02% | N/A | N/A | -1,267.20% | -302.92% | -46.77% | -2.85% | 22.43% | 30.62% | 34.70% | |
| EPS YoY % growth | -4.53 8.30% | -4.64 -2.43% | -2.28 50.86% | -2.02 11.50% | -1.90 5.67% | -1.65 13.19% | -1.37 17.13% | -0.56 59.22% | -0.13 76.26% | 0.38 384.62% | 0.99 162.16% | 1.52 53.61% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.59 4.75% | -0.43 23.86% | -0.45 -21.30% | -0.46 -25.16% | -0.44 24.70% |
| Revenue Q2Q % growth | -100.00% | ||||
| EBITDA Q2Q % growth | -38.199M 15.06% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -36.71M 20.64% | -36.535M 0.38% | -38.102M -5.67% | -39.703M -17.69% | -41.95M -14.28% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.37 33.93% | -0.54 | 0.17 | 31.28% |
| Q2 2025 Q2Q % growth | -0.37 70.16% | -0.59 | 0.22 | 37.60% |
| Q1 2025 Q2Q % growth | -0.56 -500.00% | -0.65 | 0.09 | 13.92% |
| Q4 2024 Q2Q % growth | -0.62 33.33% | -0.72 | 0.10 | 13.88% |
| Q3 2024 Q2Q % growth | -0.56 29.11% | -0.93 | 0.37 | 39.67% |
| Q2 2024 Q2Q % growth | -1.24 32.97% | -0.86 | -0.38 | -44.57% |
| Q1 2024 Q2Q % growth | 0.14 113.08% | -0.78 | 0.92 | 117.90% |
| Q4 2023 Q2Q % growth | -0.93 -1.09% | -0.93 | 0.00 | 0.45% |
| Q3 2023 Q2Q % growth | -0.79 17.71% | -0.93 | 0.14 | 15.05% |
| Q2 2023 Q2Q % growth | -1.85 -38.06% | -1.06 | -0.79 | -74.82% |
| Q1 2023 Q2Q % growth | -1.07 18.32% | -1.04 | -0.03 | -2.90% |
| Q4 2022 Q2Q % growth | -0.92 17.12% | -1.08 | 0.16 | 14.92% |
| Q3 2022 Q2Q % growth | -0.96 23.20% | -1.19 | 0.23 | 19.48% |
| Q2 2022 Q2Q % growth | -1.34 | -1.21 | -0.13 | -10.81% |
| Q1 2022 Q2Q % growth | -1.31 -5.65% | -1.24 | -0.07 | -5.70% |
| Q4 2021 Q2Q % growth | -1.11 -9.90% | -1.52 | 0.41 | 27.21% |
| Q3 2021 Q2Q % growth | -1.25 -37.36% | -1.34 | 0.09 | 6.45% |
| Q2 2021 Q2Q % growth | -1.34 -71.79% | -1.20 | -0.14 | -12.12% |
| Q1 2021 Q2Q % growth | -1.24 56.94% | -0.99 | -0.25 | -25.59% |
| Q4 2020 Q2Q % growth | -1.01 | -0.97 | -0.04 | -3.79% |
| Q3 2020 Q2Q % growth | -0.91 | -0.82 | -0.09 | -10.60% |
| Q2 2020 Q2Q % growth | -0.78 | -0.51 | -0.27 | -51.93% |
| Q1 2020 Q2Q % growth | -2.88 | -0.71 | -2.17 | -303.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -100.00% | % | ||
| Q1 2024 Q2Q % growth | 40.56M | 13.388M | 27.172M | 202.96% |
| Q1 2020 Q2Q % growth | 102K | -102K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -35.71% | -7.53% | -8.48% | 8.47% |
| Revenue | N/A | N/A | N/A | N/A |